In this KOL masterclass on demand video, Prof. Stephen Nicholls will discuss the impact of intensive lipid lowering strategies (statins, evolocumab, alirocumab) on plaque phenotype and progression.
This masterclass on-demand video is designed for health care professionals (cardiologists, lipidologists, diabetes specialists, neurologists) who are interested in learning more on the results of the latest clinical trials (GLAGOV, HUYGENS, PACMAN-AMI) on coronary disease.